Source: Wikipedia, the free encyclopedia.
Antihypertensive drug of the calcium channel blocker class
Pranidipine
|
Names
|
Preferred IUPAC name
Methyl (2E)-3-phenylprop-2-en-1-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
|
Other names
2,6-Dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid O5-methyl O3-[(E)-3-phenylprop-2-enyl] ester
|
Identifiers
|
|
|
|
|
ChEMBL
|
|
ChemSpider
|
|
MeSH
|
C048161
|
|
|
UNII
|
|
|
|
InChI=1S/C25H24N2O6/c1-16-21(24(28)32-3)23(19-12-7-13-20(15-19)27(30)31)22(17(2)26-16)25(29)33-14-8-11-18-9-5-4-6-10-18/h4-13,15,23,26H,14H2,1-3H3/b11-8+ NKey: XTFPDGZNWTZCMF-DHZHZOJOSA-N NInChI=1/C25H24N2O6/c1-16-21(24(28)32-3)23(19-12-7-13-20(15-19)27(30)31)22(17(2)26-16)25(29)33-14-8-11-18-9-5-4-6-10-18/h4-13,15,23,26H,14H2,1-3H3/b11-8+ Key: XTFPDGZNWTZCMF-DHZHZOJOBA
|
|
Properties
|
|
C25H24N2O6
|
Molar mass
|
448.46786
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Chemical compound
Pranidipine is a
dihydropyridine group.
[1]
References
VDCCsTooltip Voltage-dependent calcium channels
| |
---|
VGKCsTooltip Voltage-gated potassium channels | |
---|
IRKsTooltip Inwardly rectifying potassium channel | |
---|
KCaTooltip Calcium-activated potassium channel | |
---|
K2PsTooltip Tandem pore domain potassium channel | |
---|
VGSCsTooltip Voltage-gated sodium channels | |
---|
ENaCTooltip Epithelial sodium channel | |
---|
ASICsTooltip Acid-sensing ion channel | |
---|
CaCCsTooltip Calcium-activated chloride channel | |
---|
CFTRTooltip Cystic fibrosis transmembrane conductance regulator | |
---|
Unsorted | |
---|
Others | Tooltip Transient receptor potential channels | |
---|
Tooltip Ligand gated ion channels | |
---|
|
---|
|